A lawsuit was filed by investor in shares of Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) in effort to stop the proposed takeover and NASDAQ:SLXP stockholders should contact the Shareholders Foundation.

San Diego, CA -- (SBWire) -- 08/20/2014 --An investor, who currently holds shares of Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) filed a lawsuit in effort to halt the proposed takeover of Salix Pharmaceuticals, Ltd. by Cosmo Pharmaceuticals S.p.A.

Investors who purchased shares of Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) and currently hold any of those NASDAQ:SLXP shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The plaintiff alleges that the defendants breached their fiduciary duties owed to NASDAQ:SLXP stockholders by agreeing to sell Salix Pharmaceuticals, Ltd.. too cheaply via an unfair process to Cosmo Pharmaceuticals S.p.A.

On July 8, 2014, Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) and Cosmo Pharmaceuticals S.p.A. (SIX: COPN) announced a merger agreement under which Salix will combine with Cosmo Technologies Limited, a subsidiary of Cosmo Pharmaceuticals S.p.A.

However, the plaintiff claims that the offer is unfair to NASDAQ: SLXP stockholders and undervalues Salix Pharmaceuticals, Ltd.

Indeed, Salix Pharmaceuticals, Ltd. reported that its annual Total Revenue rose from $336.97 million in 2010 to $933.84 million in 2013 and that its Net Loss of $27.06 million in 2010 turned into a Net income of $143.03 million in 2013. Shares of Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) grew from $27.78 per share in September 2011 to as high as $140.02 per share on July 1, 2014.

On August 18, 2014, NASDAQ:SLXP shares closed at $139.17 per share.

Those who are current investors in Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) shares have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Joelle Day
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com